U.s. Army Medical Research And Development Command
Clinical trials sponsored by U.s. Army Medical Research And Development Command, explained in plain language.
-
New HIV vaccine candidate moves to human safety testing
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental HIV vaccine in 65 healthy, HIV-negative adults to see if it is safe and triggers an immune response. Participants received three shots over two months, each with a different dose of an immune-boosting ingredient called ALFQ. The goal was to find …
Phase: PHASE1 • Sponsor: U.S. Army Medical Research and Development Command • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:24 UTC
-
New rapid test could speed up diagnosis of parasitic skin disease
Diagnosis CompletedThis study tested a new rapid test called CL Detect™ for diagnosing cutaneous leishmaniasis, a skin disease from sand fly bites. Researchers compared the test to the standard method (looking at samples under a microscope) in 150 adults with skin ulcers. The goal was to see how ac…
Sponsor: U.S. Army Medical Research and Development Command • Aim: Diagnosis
Last updated May 26, 2026 08:24 UTC
-
New vaccine could block deadly botulism toxin
Prevention CompletedThis study tested a vaccine called G03-52-01 in 622 healthy adults to see if it is safe and can produce antibodies that neutralize botulinum toxin, the cause of botulism. Participants received either the vaccine or a placebo, and researchers measured immune responses and side eff…
Phase: PHASE2 • Sponsor: U.S. Army Medical Research and Development Command • Aim: Prevention
Last updated May 22, 2026 14:02 UTC